Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03913377 · ClinicalTrials.gov registry record · NA
Ocular Characteristics in Contact Lens and Spectacle Wear
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT03913377 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 78 participants.
The verdict
NCT03913377, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
This clinical study will investigate the difference in ocular characteristics between contact lens wear and spectacle wear among habitual contact lens wearers, using a 2-treatment by 2-period cross-over design. There will be a 1-week washout between the two study periods to eliminate any potential carryover effect.
Interventions
- DEVICE Spectacles
- DEVICE ACUVUE OASYS®1-Day with HydraLuxe™ Technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2019-04-09 |
| Est. Completion | 2019-06-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03913377
The ClinicalTrials.gov registry entry for NCT03913377 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Spectacles is the first listed.
NCT03913377 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03913377 about?
NCT03913377 is a clinical study titled "Ocular Characteristics in Contact Lens and Spectacle Wear". This clinical study will investigate the difference in ocular characteristics between contact lens wear and spectacle wear among habitual contact lens wearers, using a 2-treatment by 2-period cross-over design. There will be a 1-week washout between the two study periods to eliminate any potential c...
What is the current status of trial NCT03913377?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2019-04-09. Estimated completion is 2019-06-14.
What interventions are being tested in trial NCT03913377?
The interventions under investigation include: Spectacles (DEVICE), ACUVUE OASYS®1-Day with HydraLuxe™ Technology (DEVICE).
Who is sponsoring clinical trial NCT03913377?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.